company-logo

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Bluejay Diagnostics Dividend Announcement

Bluejay Diagnostics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Bluejay Diagnostics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Bluejay Diagnostics Dividend History

Bluejay Diagnostics Dividend Yield

Bluejay Diagnostics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bluejay Diagnostics stock? Use our calculator to estimate your expected dividend yield:

Bluejay Diagnostics Financial Ratios

P/E ratio-4.52
PEG ratio0.09
P/B ratio5.42
ROE-155.68%
Payout ratio0.00%
Current ratio6.26
Quick ratio6.26
Cash Ratio5.49

Bluejay Diagnostics Dividend FAQ

Does Bluejay Diagnostics stock pay dividends?
Bluejay Diagnostics does not currently pay dividends to its shareholders.
Has Bluejay Diagnostics ever paid a dividend?
No, Bluejay Diagnostics has no a history of paying dividends to its shareholders. Bluejay Diagnostics is not known for its dividend payments.
Why doesn't Bluejay Diagnostics pay dividends?
There are several potential reasons why Bluejay Diagnostics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bluejay Diagnostics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bluejay Diagnostics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bluejay Diagnostics a dividend aristocrat?
Bluejay Diagnostics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bluejay Diagnostics a dividend king?
Bluejay Diagnostics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bluejay Diagnostics a dividend stock?
No, Bluejay Diagnostics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bluejay Diagnostics stocks?
To buy Bluejay Diagnostics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bluejay Diagnostics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.